Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Pneumothorax | Research

Native-lung complications following single-lung transplantation for interstitial lung disease: an in-depth analysis

Authors: Toshikazu Watanabe, Takashi Hirama, Ken Onodera, Hirotsugu Notsuda, Hisashi Oishi, Hiromichi Niikawa, Kazuyoshi Imaizumi, Yoshinori Okada

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Interstitial lung disease (ILD) represents a heterogeneous group of lung disorders characterized by fibrotic lung tissue changes. In regions with severe donor shortages, single-lung transplantation (SLTx) is often preferred over bilateral lung transplantation for advanced ILD. However, temporal changes and complications in the retained native lung remain poorly understood.

Methods

A retrospective analysis of 149 recipients who had undergone SLTx was conducted, including 34 ILD SLTx recipients. Native-lung volume, radiological alterations, and perfusion were assessed at distinct post-SLTx time points. Statistical analyses compared ILD and non-ILD SLTx groups.

Results

Our study revealed a progressive reduction in native-lung volume over time, accompanied by radiographic deterioration and declining perfusion. Complications in the retained native lung were observed, such as pneumothorax (29.4%), pulmonary aspergillosis (11.8%), and acute exacerbation (8.9%). Long-term survival rates were similar between ILD and non-ILD SLTx recipients.

Conclusions

This study illuminates the unique challenges and complications with respect to the native lung following SLTx for ILD. Ongoing monitoring and tailored management are essential. Despite limitations, this research contributes to our understanding of the temporal progression of native-lung complications post-SLTx for ILD, underscoring the need for further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fukushima N, Ono M, Nakatani T, Minami M, Konaka S, Ashikari J. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplant Proc. 2009;41:273–6. Fukushima N, Ono M, Nakatani T, Minami M, Konaka S, Ashikari J. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplant Proc. 2009;41:273–6.
3.
go back to reference Hirama T, Akiba M, Watanabe T, Watanabe Y, Notsuda H, Oishi H, et al. Waitlist Mortality in lung transplant candidates in Japan. Transplantation. 2022;106:1507–9.CrossRefPubMed Hirama T, Akiba M, Watanabe T, Watanabe Y, Notsuda H, Oishi H, et al. Waitlist Mortality in lung transplant candidates in Japan. Transplantation. 2022;106:1507–9.CrossRefPubMed
4.
go back to reference Brown AW, Kaya H, Nathan SD. Lung transplantation in IIP: a review. Respirology. 2016;21:1173–84.CrossRefPubMed Brown AW, Kaya H, Nathan SD. Lung transplantation in IIP: a review. Respirology. 2016;21:1173–84.CrossRefPubMed
5.
go back to reference Kapnadak SG, Raghu G. Lung transplantation for interstitial lung disease. Eur Respir Rev. 2021;30. Kapnadak SG, Raghu G. Lung transplantation for interstitial lung disease. Eur Respir Rev. 2021;30.
6.
go back to reference Elicker BM, Golden JA, Ordovas KG, Leard L, Golden TR, Hays SR. Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis. Respir Med. 2010;104:426–33.CrossRefPubMed Elicker BM, Golden JA, Ordovas KG, Leard L, Golden TR, Hays SR. Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis. Respir Med. 2010;104:426–33.CrossRefPubMed
7.
go back to reference Hinze AM, Lin CT, Hussien AF, Perin J, Venado A, Golden JA, et al. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma. Rheumatology. 2020;59:790–8.CrossRefPubMed Hinze AM, Lin CT, Hussien AF, Perin J, Venado A, Golden JA, et al. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma. Rheumatology. 2020;59:790–8.CrossRefPubMed
8.
go back to reference Hirama T, Akiba M, Watanabe T, Watanabe Y, Notsuda H, Oishi H, et al. Waiting time and mortality rate on lung transplant candidates in Japan: a single-center retrospective cohort study. BMC Pulm Med. 2021;21:1–9.CrossRef Hirama T, Akiba M, Watanabe T, Watanabe Y, Notsuda H, Oishi H, et al. Waiting time and mortality rate on lung transplant candidates in Japan: a single-center retrospective cohort study. BMC Pulm Med. 2021;21:1–9.CrossRef
9.
go back to reference Hirama T, Tomiyama F, Notsuda H, Watanabe T, Watanabe Y, Oishi H, et al. Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis. BMC Pulm Med. 2021;21:261.CrossRefPubMedPubMedCentral Hirama T, Tomiyama F, Notsuda H, Watanabe T, Watanabe Y, Oishi H, et al. Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis. BMC Pulm Med. 2021;21:261.CrossRefPubMedPubMedCentral
10.
go back to reference Nikkuni E, Hirama T, Hayasaka K, Kumata S, Kotan S, Watanabe Y, et al. Recovery of physical function in lung transplant recipients with Sarcopenia. BMC Pulm Med. 2021;21:124.CrossRefPubMedPubMedCentral Nikkuni E, Hirama T, Hayasaka K, Kumata S, Kotan S, Watanabe Y, et al. Recovery of physical function in lung transplant recipients with Sarcopenia. BMC Pulm Med. 2021;21:124.CrossRefPubMedPubMedCentral
11.
go back to reference Katahira M, Hirama T, Eba S, Suzuki T, Notsuda H, Oishi H, et al. Impact of postoperative continuous renal replacement therapy in lung transplant recipients. Transpl Direct. 2020;6:e562.CrossRef Katahira M, Hirama T, Eba S, Suzuki T, Notsuda H, Oishi H, et al. Impact of postoperative continuous renal replacement therapy in lung transplant recipients. Transpl Direct. 2020;6:e562.CrossRef
12.
go back to reference Kumata S, Hirama T, Watanabe Y, Oishi H, Niikawa H, Akiba M, et al. The fraction of sensitization among lung transplant recipients in a transplant center in Japan. BMC Pulm Med. 2020;20:256.CrossRefPubMedPubMedCentral Kumata S, Hirama T, Watanabe Y, Oishi H, Niikawa H, Akiba M, et al. The fraction of sensitization among lung transplant recipients in a transplant center in Japan. BMC Pulm Med. 2020;20:256.CrossRefPubMedPubMedCentral
13.
go back to reference Ui M, Hirama T, Akiba M, Honda M, Kikuchi T, Okada Y. Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan. Vaccine. 2023;41:4534–40.CrossRefPubMed Ui M, Hirama T, Akiba M, Honda M, Kikuchi T, Okada Y. Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan. Vaccine. 2023;41:4534–40.CrossRefPubMed
14.
go back to reference Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–7.CrossRefPubMed Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–7.CrossRefPubMed
15.
go back to reference Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991;18:1520–8.PubMed Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991;18:1520–8.PubMed
16.
go back to reference Kumar I, Siddiqui Z, Verma A, Chokhani A, Srivastava GN, Shukla RC. Performance of semi-quantitative lung ultrasound in the assessment of disease severity in interstitial lung disease. Ann Thorac Med. 2021;16:110–7.CrossRefPubMedPubMedCentral Kumar I, Siddiqui Z, Verma A, Chokhani A, Srivastava GN, Shukla RC. Performance of semi-quantitative lung ultrasound in the assessment of disease severity in interstitial lung disease. Ann Thorac Med. 2021;16:110–7.CrossRefPubMedPubMedCentral
17.
go back to reference Glenn LM, Troy LK, Corte TJ. Novel diagnostic techniques in interstitial lung disease. Front Med (Lausanne). 2023;10:1174443.CrossRefPubMed Glenn LM, Troy LK, Corte TJ. Novel diagnostic techniques in interstitial lung disease. Front Med (Lausanne). 2023;10:1174443.CrossRefPubMed
18.
go back to reference Sarac S, Kavas M, Sahin M, Aras G, Afsar GC, Tezel YB. Relation of Warrick Score and Polysomnographic Parameters in patients with interstitial lung disease. Med Sci Monit. 2019;25:2087–95.CrossRefPubMedPubMedCentral Sarac S, Kavas M, Sahin M, Aras G, Afsar GC, Tezel YB. Relation of Warrick Score and Polysomnographic Parameters in patients with interstitial lung disease. Med Sci Monit. 2019;25:2087–95.CrossRefPubMedPubMedCentral
19.
go back to reference King CS, Khandhar S, Burton N, Shlobin OA, Ahmad S, Lefrak E, et al. Native lung complications in single-lung transplant recipients and the role of pneumonectomy. J Heart Lung Transpl. 2009;28:851–6.CrossRef King CS, Khandhar S, Burton N, Shlobin OA, Ahmad S, Lefrak E, et al. Native lung complications in single-lung transplant recipients and the role of pneumonectomy. J Heart Lung Transpl. 2009;28:851–6.CrossRef
20.
go back to reference Gonzalez FJ, Alvarez E, Moreno P, Poveda D, Ruiz E, Fernandez AM, et al. The influence of the native lung on early outcomes and survival after single lung transplantation. PLoS ONE. 2021;16:e0249758.CrossRefPubMedPubMedCentral Gonzalez FJ, Alvarez E, Moreno P, Poveda D, Ruiz E, Fernandez AM, et al. The influence of the native lung on early outcomes and survival after single lung transplantation. PLoS ONE. 2021;16:e0249758.CrossRefPubMedPubMedCentral
21.
go back to reference Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transpl. 2003;22:258–66.CrossRef Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transpl. 2003;22:258–66.CrossRef
22.
go back to reference Colquhoun IW, Gascoigne AD, Gould K, Corris PA, Dark JH. Native pulmonary sepsis after single-lung transplantation. Transplantation. 1991;52:931–3.CrossRefPubMed Colquhoun IW, Gascoigne AD, Gould K, Corris PA, Dark JH. Native pulmonary sepsis after single-lung transplantation. Transplantation. 1991;52:931–3.CrossRefPubMed
23.
go back to reference Goletto T, Decaux S, Bunel V, Weisenburger G, Messika J, Najem S, et al. Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports. J Med Case Rep. 2022;16:2.CrossRefPubMedPubMedCentral Goletto T, Decaux S, Bunel V, Weisenburger G, Messika J, Najem S, et al. Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports. J Med Case Rep. 2022;16:2.CrossRefPubMedPubMedCentral
24.
go back to reference Marron RM, Vega Sanchez ME, Clauss H, Mamary AJ. Acute Hypoxemic Respiratory Failure and Native Lung Idiopathic Pulmonary Fibrosis Exacerbation in Single-lung Transplant Patients with Cytomegalovirus Disease: A Case Series. Transplant Proc. 2019;51:3391–4. Marron RM, Vega Sanchez ME, Clauss H, Mamary AJ. Acute Hypoxemic Respiratory Failure and Native Lung Idiopathic Pulmonary Fibrosis Exacerbation in Single-lung Transplant Patients with Cytomegalovirus Disease: A Case Series. Transplant Proc. 2019;51:3391–4.
25.
go back to reference Khawar MU, Yazdani D, Zhu Z, Jandarov R, Dilling DF, Gupta N. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. J Heart Lung Transpl. 2019;38:949–55.CrossRef Khawar MU, Yazdani D, Zhu Z, Jandarov R, Dilling DF, Gupta N. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. J Heart Lung Transpl. 2019;38:949–55.CrossRef
26.
go back to reference Warrior K, Dilling DF. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transpl. 2023;42:40–52.CrossRef Warrior K, Dilling DF. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transpl. 2023;42:40–52.CrossRef
Metadata
Title
Native-lung complications following single-lung transplantation for interstitial lung disease: an in-depth analysis
Authors
Toshikazu Watanabe
Takashi Hirama
Ken Onodera
Hirotsugu Notsuda
Hisashi Oishi
Hiromichi Niikawa
Kazuyoshi Imaizumi
Yoshinori Okada
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-03009-6

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine